Seelos Therapeutics
SEEL
#10255
Rank
A$0.34 M
Marketcap
$0.59
Share price
-31.49%
Change (1 day)
-99.81%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): A$6.95 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$60.19 Million, an increase over its 2022 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$6.95 M-111.56%
2023 -A$60.19 Million-48.58%
2022 -A$0.12 Billion14.07%
2021 -A$0.11 Billion240.34%
2020 -A$30.15 Million-62.76%
2019 -A$80.96 Million587.73%
2018 -A$11.78 Million-36.54%
2017 -A$18.55 Million74.83%
2016 -A$10.61 Million-63.26%
2015 -A$28.88 Million-18.06%
2014 -A$35.25 Million46.19%
2013 -A$24.11 Million-31.67%
2012 -A$35.29 Million
2010 -A$33.06 Million448.63%
2009 -A$6.03 Million-25.83%
2008 -A$8.13 Million-45.65%
2007 -A$14.95 Million2.82%
2006 -A$14.54 Million-41.86%
2005 -A$25 Million-9.27%
2004 -A$27.55 Million114.92%
2003 -A$12.82 Million-70.78%
2002 -A$43.88 Million60.2%
2001 -A$27.39 Million70.3%
2000 -A$16.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-3,309.93%๐Ÿ‡บ๐Ÿ‡ธ USA